Medvi Review: Compounded GLP-1, Safety Concerns, and What’s Missing

Medvi provides access to comprehensive weight management care, which primarily includes compounded GLP-1 medications/injectables and expert-backed support from licensed healthcare providers.

The brand’s online platform may help you bypass the barriers associated with in-person clinic visits, such as long wait times or insurance paperwork. Medvi may also provide you with prescription delivery of GLP-1 medications straight to your door.

In this review, we provide a breakdown of Medvi’s service model, platform features, available services, advantages, and potential brand limitations. To provide a better understanding, the review also compares Medvi with two competitive telehealth platforms engaged in the weight management space.

About Medvi

Medvi is a telehealth and prescription delivery platform that aims to provide you with convenient and discreet access to compounded GLP-1 medications in the form of injectables and tablets. These GLP-1 medications may help suppress appetite and support healthy blood sugar levels, which may support your fitness goals.

Medvi also provides access to a brand-name GLP‑1 injection called Ozempic®. It could mimic the GLP-1 (glucagon-like peptide-1) hormone, which could slow gastric emptying, so food stays in the stomach longer, promoting a feeling of fullness.

To get started with MEDVi, you need to fill out a detailed online questionnaire that licensed Medvi healthcare providers review. Based on your medical profile, the doctors at Medvi may recommend a personalized weight management plan. Once approved, prescription medications are shipped directly to your home from U.S.-licensed partner pharmacies.

Medvi Products

1. Compounded GLP-1 Injections

   Under the Personalized Care category, Medvi provides access to prescription, compounded GLP-1 injections. These injections typically contain GLP-1 receptor agonists like semaglutide, which could help improve insulin sensitivity, minimize food cravings, and support metabolism. Such effects may help contribute to your fitness goals. MEDVi’s Personalized Care program is structured around weekly self-administered GLP-1 injections.

   According to the official site, the pricing for MEDVi’s GLP-1 injections starts at $179 for the first month, which covers the cost of your physician review, metabolic report, full personalized plan, 1:1 guidance, and shipping.

   While Medvi provides access to compounded GLP-1 medications, it’s important to note that these compounded GLP-1 injections do not hold the FDA-approved status of brand-name GLP-1 options like Ozempic® or Wegovy®.

2. Compounded GLP-1 Tablets

   Medvi provides access to GLP‑1 tablets that feature compounded GLP‑1 receptor agonists (like semaglutide) in an oral format. The GLP‑1 tablets provided by Medvi may be particularly helpful if you prefer a non-invasive means to support metabolism and weight management goals.

   As per the official site, MEDVi’s GLP‑1 tablets require you to consume one tablet daily, whose pricing starts at $249. Opting for GLP-1 tablets might also minimize some risks associated with needles, such as injection-site infections, bruising, or localized inflammation.

3. Ozempic® Injection

   Beyond compounded options, Medvi also provides brand-name GLP-1 injections like Ozempic®. Ozempic may help signal beta cells in the pancreas to release insulin, particularly after meals, which could help stabilize blood sugar levels and minimize the risk of hypoglycemia. It may also help promote satiety by delaying gastric emptying, thereby reducing overeating.

   Research highlights that semaglutide (Ozempic®), administered at 0.5–1 mg weekly injections in participants with type 2 diabetes, showed a noticeable body weight reduction versus a placebo. It also improved parameters of glycemic control and decreased cardiovascular risk factors.

   According to the official site, the Ozempic® injections are subject to availability as their quantities are limited, with prices starting from $1999 per month. It is important to note that Ozempic® may trigger constipation, abdominal pain, nausea, and vomiting, especially in the initial weeks as your body adjusts.

Medvi Advantages

1. Integrated Lifestyle Personalization

   As a platform, Medvi integrates lifestyle personalization into its care model by tailoring weight management plans to fit your specific fitness background and daily habits. The process begins with a comprehensive questionnaire, where you provide details about your medical history, current medications, chronic conditions (such as hypertension or type 2 diabetes), and lifestyle factors (like sleep, eating patterns, and activity levels). Based on such insights, the Medvi platform offers access to a weight-management plan that may include either branded GLP‑1 medication (such as Ozempic®) or compounded alternatives (like GLP-1 tablets or injections), depending on eligibility and insurance status.

   Besides providing access to GLP‑1 medications, the Medvi platform also provides ongoing support in areas like nutrition, hydration, and side effect management to make the weight management plan more sustainable over time. Such an approach may align your care plan with your lifestyle rather than forcing you to adapt to a rigid program.

2. Ongoing Physician-Led Oversight

   The Medvi platform offers a structured approach to ongoing physician-led oversight. From the beginning of your care, Medvi connects you with a U.S.-licensed physician who manages your weight management plan through virtual consultations. For instance, the MEDVi’s medical staff includes board-certified clinicians like Dr. Ana Lisa Carr, Dr. David Mansour, and Dr. Kelly Tenbrink.

   Medvi emphasizes continued physician involvement for dose titration, side effect tracking, and clinical decision-making. The same care team typically follows your progress, providing continuity and expert supervision across all stages of your weight management plan. Whether you’re using branded or compounded therapies, the presence of a physician oversight might help lower the risk of unmanaged side effects or dosing errors, and help keep your care plan aligned with evolving medical needs.

Medvi Limitation

1. Lack of Published Clinical Evidence for Compounded Versions

   The Medvi platform primarily offers access to compounded GLP-1 medications, such as compounded semaglutide. Such compounded GLP-1 medications do not hold the FDA-approved status of brand-name GLP-1 options like Wegovy® or Mounjaro®. It means that there is no peer-reviewed research or large-scale clinical trials specific to the compounded versions of GLP-1 medications provided by the Medvi platform, which may raise concerns about their safety, effectiveness, or consistency.

   Moreover, the FDA has warned that some compounding pharmacies may use salt forms of semaglutide (like semaglutide sodium), which are not tested for safety or effectiveness in humans. The Medvi platform’s use of compounded GLP-1 medications may become a major drawback if you’re looking for evidence-based care.

   Other telehealth platforms like FuturHealth and Clinic Secret also offer compounded GLP-1 options, but they place greater visibility and preference on FDA-approved medications. For instance, the Clinic Secret provides access to brand-name GLP-1 options like Wegovy® and Ozempic®, while FuturHealth offers access to Ozempic®, Zepbound®, and Mounjaro®. On the other hand, under the brand-name category, the Medvi platform only provides access to Ozempic®.

Alternatives To MedVi

1. Clinic Secret

   When comparing Clinic Secret and MedVi, the brands diverge on aspects like the range of their offerings, pharmacy affiliations, and pricing. Clinic Secret provides access to both compounded and brand-name GLP-1 medications, such as tirzepatide, semaglutide, Wegovy®, and Ozempic®.

   On the other hand, Medvi primarily focuses on compounded GLP-1 medications (like semaglutide), which it offers as GLP-1 Injections and GLP-1 Tablets. Beyond compounded options, Medvi also offers Ozempic® Injection under the branded category.

   In terms of pricing, the exact pricing structure of Clinic Secret’s GLP-1 offerings is not disclosed on its official site. The platform only states that the pricing of GLP-1 formulations on Clinic Secret may vary depending on supply and dosage needs. Meanwhile, Medvi offers more transparency regarding the pricing of its GLP-1 offerings. For example, the GLP-1 Injections and GLP-1 Tablets start at $179 and $249, respectively. Ozempic® Injection from Medvi is priced at a monthly subscription cost of $1999.

   From the perspective of pharmacy affiliations, Clinic Secret lists two specific compounding pharmacy partners, namely Manifest Pharmacy and Red Rock Home Pharmacy. Meanwhile, Medvi is not transparent about any specifics of its pharmacy labs. It claims to collaborate with multiple U.S.-certified pharmacies, but does not mention the names of such affiliations.

   Both Clinic Secret and Medvi platforms maintain updated terms and privacy policies. For instance, Clinic Secret includes HIPAA protections, telehealth consent protocols, and clear disclaimers about emergency care limitations. Similarly, Medvi features a LegitScript certification, implying that it meets high standards for safety, transparency, and legal compliance in online healthcare.

2. FuturHealth

   When comparing the telehealth platforms, FuturHealth and Medvi differ in the range of the GLP‑1 medications they provide. FuturHealth provides access to Ozempic®, Zepbound®, and Mounjaro®, and GLP-1 + GIP medications.

   On the other hand, Medvi mainly offers access to compounded GLP‑1 medications (both injections and tablets), while also providing access to the brand-name Ozempic® injection.

   In terms of pricing, the telehealth models of FuturHealth and Medvi are structured differently. FuturHealth does not maintain transparency in pricing, but it only discloses that FuturHealth plans start from $99 per month. Meanwhile, Medvi adopts a more transparent model, listing its pricing openly, which includes $179 for compounded GLP-1 injections, $249 for GLP-1 tablets, and $1,999 per month for Ozempic® injection.

   Both FuturHealth and Medvi provide access to GLP-1 medications, but their program structures differ significantly in focus and support.

   FuturHealth integrates medication with a lifestyle-oriented model that includes personalized meal plans, weekly nutrition updates, metabolic testing, and one-on-one coaching from registered dietitians, all designed to support long-term behavioral change.

   Meanwhile, Medvi prioritizes clinical accessibility, offering 24/7 messaging with physicians, virtual appointments, and discreet delivery of compounded GLP-1 formulations. While FuturHealth emphasizes nutritional structure and coaching, Medvi centers on flexible medical oversight without including structured dietary or educational support.

   Support availability is another distinguishing factor. Medvi claims to provide around-the-clock access to healthcare providers via unlimited messaging and virtual appointments. On the other hand, the FuturHealth platform also offers access to coaching and telehealth consultations, does not specifically promote 24/7 availability.

Also See: UrWay Health

How Did We Evaluate MEDVi?

1. Brand Credibility

   In evaluating MEDVi’s brand reputation, we examined its background, online presence, and reputation across trusted third-party review platforms. Information about the brand’s founding date or corporate history is unspecified. However, Medvi positions itself as a digital healthcare provider specializing in telemedicine consultations and prescription deliveries of GLP-1 medications.

   On Trustpilot, Medvi holds a 4.2 out of 5 rating based on 2,100+ reviews, indicating a mostly positive customer experience. Most customers highlighted convenience, fast delivery, and user-friendly service. However, some reviews also mention delays in communication or support, pointing to occasional service inconsistencies.

   It’s worth noting that Medvi currently lacks a verified presence on other major review platforms, such as BBB (Better Business Bureau), Reviews.io, and TenereTeam. Such an absence of Medvi on these reputable review forums might limit the scope of the brand’s trustworthiness.

2. Real User Reviews

   To assess MEDVi’s real-world standing, we analyzed multiple verified customer experiences shared on Reddit. User feedback on Reddit has revealed a mixed response to MEDVi. Many users who received prescription GLP-1 medications from Medvi reported losing 6–12 pounds over a few months, with some consumers noting a reduction in appetite and clothing sizes. Some customers also praised MEDVi’s straightforward process that provided prompt online assessments and medication delivery.

   However, some users flagged long delays in shipment, unclear billing practices, and unexplained price hikes. For instance, one Reddit user expressed being charged $544 (in the second month) after initially paying $279 for the same medication in the first month. Some reviews also highlighted that medications arrived in unbranded containers, leading to doubts about legitimacy.

   Reviews also highlighted inconsistent onboarding procedures, as some consumers were required to engage in video consultations while others did not. These contrasting reviews may suggest that MEDVi’s service quality may depend on the user’s location, expectations, and individual experience.

Frequently Asked Questions

1. Are the GLP-1 Medications From Medvi FDA-Approved to Support Weight Loss?
   No, Medvi mainly provides compounded GLP-1 medications, which are not FDA-approved to support weight management. Even the brand-name Ozempic is made accessible by MEDVi, but it is only FDA-approved for managing type 2 diabetes, not weight loss.
2. Which Brand-Name GLP-1 Medications Does Medvi Provide?
   Medvi offers access to Ozempic and Wegovy (injection only) under brand-name GLP-1 medications, but branded tirzepatide options are not available through the platform.
3. Can I Cancel My Medvi Membership At Any Time?
   Yes, subscription memberships provided by Medvi may be canceled anytime, though refunds are not granted for prescriptions already dispensed or shipped.
4. Is There A Risk of Shortage or Medication Unavailability With MEDVi?
   As with any virtual telehealth platform that provides access to GLP-1 medications, increased demand or supply disruptions may cause medication shortages, particularly for brand-name GLP-1 medications.

Final Words

The Medvi platform can provide access to weight management care through compounded GLP-1 medications, lifestyle coaching, and round-the-clock virtual consultations.

Medvi’s primary offerings center around compounded versions of GLP-1 medications, such as injections and tablets, with one branded version of Ozempic, which might support your weight management goals when paired with guided behavioral and lifestyle changes.

However, MEDVi’s care plans rely heavily on compounded GLP-1 medications that are not FDA-approved and lack peer-reviewed clinical evidence validating their safety or efficacy. Unlike brand-name GLP-1 medications such as Wegovy® or Zepbound®, these compounded alternatives have not undergone large-scale testing and may be potentially unsafe.

Beyond medication concerns, Medvi presents other platform-specific limitations. The brand does not publish transparent details about its compounding pharmacies or third-party safety verification processes. You may also encounter less flexibility in medication selection, particularly if seeking branded GLP-1 medications or insurance-covered alternatives.

Moreover, the fitness outcomes expected from Medvi may depend on the frequency of use of GLP-1 medications, metabolic profile, age, and adherence to tailored lifestyle changes. It is also important to note that GLP-1 medications, including those offered by the Medvi platform, may trigger potential side effects like nausea, fatigue, vomiting, or gastrointestinal discomfort.

Choosing Medvi ultimately comes down to how its model fits with your health priorities, risk tolerance, and expectations. While the platform provides a streamlined route to GLP-1 options, you should weigh its accessibility and affordability against the medical and regulatory trade-offs involved.